Nephros, Inc. (NEPH) Prices 937.5K Share Common Offering at $8/Sh

Nephros, Inc. (NASDAQ: NEPH) today announced the pricing of a firm commitment underwritten offering of 937,500 shares of common stock at a price to the public of $8.00 per share for aggregate gross proceeds of approximately $7,500,000, before underwriting discounts and offering expenses. The offering is expected to close on or about February 4, 2020, subject to the satisfaction of customary closing conditions.

Craig-Hallum Capital Group is acting as sole managing underwriter for the offering.

Maxim Group LLC and The Benchmark Company, LLC are each acting as financial advisors to Nephros.

Net proceeds of the offering, after underwriting discounts but before offering expenses, are expected to be approximately $7,050,000. Nephros intends to use the net proceeds of the offering for working capital and general corporate purposes.

You May Also Be Interested In

• Sky Harbour adds $10M via share sale to M-Cor Capital
• Oruka Therapeutics (ORKA) files $1B mixed shelf
• Aveanna Healthcare prices secondary offering at $11.75 per share